iZotope Garners $7,500,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2297ee11-213b-4fe9-85f5-af036c8b229e Date 6/23/2016 Company Name iZotope Mailing Address 60 Hampshire St., Cambridge, MA 02139 USA Company Description Driven by a passion for audio, iZotope develops innovative products that inspire and enable people to be creative. Based in Cambridge, MA, the iZotope team has spent over 15 years developing award-winning audio production tools … Continue reading “iZotope Garners $7,500,000 Series B Funding”

IFM Therapeutics Receives $27,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1922cbca-57cd-42be-b30f-c41aa4aad54f Date 6/23/2016 Company Name IFM Therapeutics Mailing Address 400 Technology Square 10th Floor Cambridge, MA 02139 USA Company Description At IFM Therapeutics, we are driven to invent transformative therapies to improve the lives of patients with serious, life threatening diseases. We are passionate about building a company that embraces creativity, integrity, … Continue reading “IFM Therapeutics Receives $27,000,000 Series A Round”

128 Technology Lands $36,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2cc7232f-b391-43dc-b626-c64c5fea53d2 Date 6/23/2016 Company Name 128 Technology Mailing Address 200 Wheeler Road Burlington, MA 01803 USA Company Description 128 Technology understands that for many companies, the network is a core part of their business – and in some cases, the network is their core business. Website http://www.128technology.com Transaction Type Venture Equity Transaction … Continue reading “128 Technology Lands $36,000,000 New Funding”

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases

So far, the story of IBM Watson Health has been mostly about growth and potential. Today, it’s more about action. The healthcare computing giant, now headquartered in Cambridge, MA, is unveiling a collaborative effort in medical imaging that includes partnerships with health systems, radiology providers, tech companies, and academic medical centers. Watson Health is pushing … Continue reading “IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases”

LightCyber Reaps $20M To Advance Its Cyberattack Detection Services

LightCyber, a cybersecurity company that specializes in detecting hackers once they’ve breached the outer defenses of a data network, announced today it raised $20 million in a Series B financing round. The venture round was led by Claltech, an Israeli division of New York-based global investment group Access Industries, and veteran security entrepreneur and investor … Continue reading “LightCyber Reaps $20M To Advance Its Cyberattack Detection Services”

Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case

Because public investors have had a more discerning attitude toward biotech IPOs this year, insiders have had to step up to help their companies go public. One extreme example is Selecta Biosciences, which just priced its offering late Tuesday with its pre-IPO investors likely buying around 60 percent of the shares. Selecta, of Watertown, MA, … Continue reading “Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case”

Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases

There is no shortage of companies out there trying to tweak our immune systems in one way or another to treat diseases like cancer. Today, IFM Therapeutics, a new startup seeded by Boston firm Atlas Venture, has joined the fray. IFM, a startup in Cambridge, MA, disclosed a $27 million Series A round led by … Continue reading “Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases”

Weave Visual Analytics Lands $750,000 Seed Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=074a6ca6-d047-4ef7-9457-dd61b9cb7950 Date 6/22/2016 Company Name Weave Visual Analytics Mailing Address Undisclosed Lowell, MA 01853 USA Company Description Weave Visual Analytics (WVA) is a venture-backed provider of high-performance data visualization and analytic tools. Website http://www.iweave.com Transaction Type Venture Equity Transaction Amount $750,000 Transaction Round Seed Proceeds Purposes The company will use the funds … Continue reading “Weave Visual Analytics Lands $750,000 Seed Funding Round”

Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

[Updated, 6/21/16, 5:40pm. See below.] Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with a landmark clinical trial. Depending on timing, it could be the first to use the gene editing … Continue reading “Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial”

Boston Cybersecurity Firms Grab Cash, Protect Turf, Push Community

A few recent moves by Boston-area cybersecurity firms illustrate the various ways the sector’s members (and related companies) are trying to build their businesses and bolster measures to counter cyber threats: —Raising more cash: On Tuesday, Zerto said it tacked $20 million onto a $50 million growth financing round announced in January. The new investment was … Continue reading “Boston Cybersecurity Firms Grab Cash, Protect Turf, Push Community”

Procrastinator’s Special Ends Today for INFLUX Tomorrow Afternoon

We’re only one day away from Influx, Xconomy’s big event highlighting Boston’s newest influencers and innovators, which will take place tomorrow afternoon (June 22) at the Science Museum. And for you late decision-makers, you’re almost out of time to save on this unique event. Our Procrastinator’s Special rate ends today, and there are only a … Continue reading “Procrastinator’s Special Ends Today for INFLUX Tomorrow Afternoon”

Hospital IQ Obtains $6,249,999 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3cb4c6ec-5bf7-4e9e-a802-5c8b9e14addc Date 6/21/2016 Company Name Hospital IQ Mailing Address 320 Nevada Street Newton, MA 02460 USA Company Description Hospital IQ is the leading predictive analytics platform applying proven operations research to improve hospital operational efficiency and patient quality through smarter data-driven decision making. Website http://www.hospitaliq.com Transaction Type Venture Equity Transaction Amount $6,249,999 … Continue reading “Hospital IQ Obtains $6,249,999 New Round”

Zerto Lands $20,000,000 Series E Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2d99c183-5ef5-468e-9c93-89f4140be573 Date 6/21/2016 Company Name Zerto Mailing Address 27-43 Wormwood Street Boston, MA 02210 USA Company Description Zerto is the industry’s first hypervisor-based, virtual-aware, replication solution for tier-one applications. It closes a critical gap in cloud and enterprise business continuity and disaster recovery (BC/DR). Website http://www.zerto.com Transaction Type Venture Equity Transaction Amount … Continue reading “Zerto Lands $20,000,000 Series E Funding Round”

Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones

[Corrected, 6/21/06, 10:49 am. See below.] Internet billionaire Sean Parker’s new cancer immunotherapy institute didn’t waste time putting its $250 million to use in unexpected ways. The San Francisco-based institute, part of a massive philanthropic effort by former Facebook president Parker (pictured), is backing an experimental cancer treatment tweaked with the gene editing technology CRISPR-Cas9. … Continue reading “Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones”

GreenLight’s Philanthropic Venture Fund Opens New Office in Detroit

In 2011, Margaret Hall, co-founder and national executive director of the GreenLight Fund, first made contact with social entrepreneurs in Detroit. She wanted to discuss the idea of her philanthropic venture fund, which invests in nonprofit entities rather than startups, opening an office in the Motor City. “At the time, the people we talked to … Continue reading “GreenLight’s Philanthropic Venture Fund Opens New Office in Detroit”

See Boston’s Newest Innovators & Influencers this Wed. at INFLUX

It is just two days to Influx, our big multidisciplinary event showcasing set for the afternoon of June 22 at the Science Museum. There is still time to grab your tickets at our Procrastinator’s Special rate, which ends tomorrow. So get them now and save $80. We have an incredible lineup—covering everything from the future … Continue reading “See Boston’s Newest Innovators & Influencers this Wed. at INFLUX”

Academia, Industry Scramble to Fill Cybersecurity Talent Pipeline

There’s a number that has been quoted a lot by the cybersecurity industry in the past year: 209,000. That’s the number of unfilled U.S. jobs in the field as of March 2015, according to an analysis of Bureau of Labor Statistics numbers. And the demand for cybersecurity workers is expected to increase 53 percent by … Continue reading “Academia, Industry Scramble to Fill Cybersecurity Talent Pipeline”

Kaymbu Receives $1,920,254 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6022752-8cc2-40c3-8818-1f71e88e80d6 Date 6/20/2016 Company Name Kaymbu Mailing Address 45 Prospect Street Cambridge, MA 02139 USA Company Description The company offers an iPad-based documentation and media management solution. Website http://www.kaymbu.com Transaction Type Venture Equity Transaction Amount $1,920,254 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 33 investors participated in the offering. … Continue reading “Kaymbu Receives $1,920,254 New Financing Round”

Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug

At a medical meeting today, Cambridge, MA-based Epizyme (NASDAQ: [[ticker:EPZM]]) is providing the latest look at the most significant trial in its nine-year history, a Phase 2 study of its cancer drug tazemetostat. Epizyme for some time has touted tazemetostat as a potential treatment for a wide array of cancers that could also be safe … Continue reading “Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug”

Veering Off Topic With Accion Systems CEO Natalya Brikner

Next up in my ongoing series of unusual interviews with local tech leaders is Natalya Brikner—space technology researcher, entrepreneur, aspiring pilot, ruthless scheduler, and lover of camping. Those are just a few of the traits I learned about Brikner in our wide-ranging conversation, which was probably the wackiest yet in the series. (I never thought … Continue reading “Veering Off Topic With Accion Systems CEO Natalya Brikner”

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Long anticipated, Walgreens officially cut ties with Theranos, and the FDA both gave and denied approvals. You think a Game 7 … Continue reading “Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More”

Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle

Paratek Pharmaceuticals has stuck with its antibiotic omadacycline over the years, even as three of the company’s pharmaceutical partners bailed on the drug. Today the Boston company has taken a key step closer to proving it made the right call. Paratek (NASDAQ: [[ticker:PRTK]]) said this afternoon that omadacycline hit all its main and secondary goals … Continue reading “Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle”

Boston Tech Watch: DraftKings, Demandware, Startup Shutdown & More

This week in Boston tech, we’re tracking DraftKings merger rumors, the aftermath of the Salesforce-Demandware deal, a startup closure, new venture funding, money for cybersecurity education, and an expanding accelerator located outside the Boston area. Read on for details. —Rumors swirled this week that the two biggest online daily fantasy sports companies—Boston-based DraftKings and New … Continue reading “Boston Tech Watch: DraftKings, Demandware, Startup Shutdown & More”

Mersana Therapeutics Receives $33,000,000 Series C Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=83d86111-25c5-4221-8c34-704bdb0f14fe Date 6/16/2016 Company Name Mersana Therapeutics Mailing Address 840 Memorial Drive Cambridge, MA 02139 USA Company Description Mersana Therapeutics, Inc. (formerly Nanopharma Corp.) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs. Website http://www.mersana.com Transaction Type Venture Equity Transaction … Continue reading “Mersana Therapeutics Receives $33,000,000 Series C Financing”

FICO Buys QuadMetrics to Help Measure Corporate Cybersecurity Risk

FICO, the San Jose, CA, software analytics company, announced Tuesday it has acquired Ann Arbor, MI-based QuadMetrics, a University of Michigan cybersecurity spinout. The terms of the deal were not disclosed. FICO—known as an industry leader in measuring and understanding consumer credit risk—will soon offer “enterprise security scores” that assess a corporation’s exposure to hackers … Continue reading “FICO Buys QuadMetrics to Help Measure Corporate Cybersecurity Risk”

Balancing Risks and Opportunities: The Board’s Perspective

People start a business for many reasons. Some do it out of sheer passion, while others do it to create wealth and economic growth. Yet, underlying it all is a willingness to take risks. Entrepreneurs and established companies make risky decisions every day in the hope that those risks will translate into better opportunities, better … Continue reading “Balancing Risks and Opportunities: The Board’s Perspective”

Deathtech Startup Mylestoned Snaps Up Heirloom’s Photo-Capturing App

Mylestoned, a young Boston startup aiming to develop a more interactive and meaningful way of digitally memorializing the dead, has acquired the photo-scanning technology of Heirloom, a small San Francisco firm. Heirloom created an app for digitizing paper photos. The app uses a smartphone’s camera to quickly scan the photo, and then its software edits … Continue reading “Deathtech Startup Mylestoned Snaps Up Heirloom’s Photo-Capturing App”

With $8M Zaius Deal, Underscore.VC Makes Another Marketing Tech Bet

Underscore.VC, one of the new Boston investment firms trying to put a fresh spin on the typical venture capital model, is starting to make more noise with its debut $75 million fund. Underscore recently led an $8 million investment in Boston marketing technology startup Zaius, which marks the second investment publicly disclosed by Underscore. (The … Continue reading “With $8M Zaius Deal, Underscore.VC Makes Another Marketing Tech Bet”

Struggling Aegerion, QLT to Merge, Change Name to Novelion

It wasn’t too long ago that Aegerion Pharmaceuticals seemed to be a successful biotech turnaround story with its first drug on the market and optimism ahead. But just a few short years, a plummeting stock price and a new executive team later, Aegerion is about to merge with a Canadian biotech to survive. Cambridge, MA-based … Continue reading “Struggling Aegerion, QLT to Merge, Change Name to Novelion”

Westphal, Termeer Step Down From Verastem Board

Cambridge, MA-based Verastem (NASDAQ: [[ticker:VSTM]]) has shaken up its board of directors. Christoph Westphal, who co-founded the company in 2010, ran it as chairman and CEO in its early days, and took the company public in 2012, has stepped down from the board, as has former Genzyme CEO Henri Termeer. Westphal moved from Verastem CEO … Continue reading “Westphal, Termeer Step Down From Verastem Board”

Alcresta Lands $49,389,680 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=21659d76-5821-43f2-9a7c-80ef5dd7b6fe Date 6/15/2016 Company Name Alcresta Mailing Address One Newton Executive Park Newton, MA 02462 USA Company Description Alcresta’s enzyme expertise and proprietary platform enables novel products for those with compromised pancreatic output and malabsorption. Website http://www.alcresta.com Transaction Type Venture Equity Transaction Amount $49,389,680 Transaction Round Undisclosed Proceeds Purposes Total amount offered … Continue reading “Alcresta Lands $49,389,680 New Financing Round”

Preply Lands $1,300,000 Seed Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5877e335-f5a7-4f99-a37a-a5f4159c3625 Date 6/15/2016 Company Name Preply Mailing Address 167 Corey Rd. Brighton, MA 02135 USA Company Description Preply – is a new platform for assisting in selecting an English language tutor. We help in finding the most suitable tutor for your request. You will find our recommendations for using the platform below. … Continue reading “Preply Lands $1,300,000 Seed Funding Round”

Barefoot Scores $130M for Programmable Switch To Make Networks Smart

We’re all always watching out for those new companies whose innovations turn out to be the gateway for systemic change across many tech sectors, as early mobile devices and cloud computing services did. Palo Alto, CA-based Barefoot Networks today laid claim to that earth-mover status, emerging from stealth after two years to announce it had … Continue reading “Barefoot Scores $130M for Programmable Switch To Make Networks Smart”

128 Technology Unveils Plan to Fix the Internet With Smart Routers

Today’s Internet is a hot mess. I’m not talking about the content of the Web. I’m talking about the networking infrastructure that runs much of our modern society—from apps to businesses to communications—and how precarious it all is. It’s safe to say the Internet was not originally designed for its current use. What started as … Continue reading “128 Technology Unveils Plan to Fix the Internet With Smart Routers”

Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short

Infinity Pharmaceuticals got a new lease on life in 2014 when pharma giant AbbVie plunked down $275 million to see if the company’s blood cancer drug, duvelisib, could stand out in a crowded field. The answer came back negative today, and Cambridge, MA-based Infinity has decided to gut its workforce as a result. Though duvelisib … Continue reading “Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short”

Cycle Computing Obtains New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5f3a3cf8-b1eb-4934-b7be-09f66f777b53 Date 6/14/2016 Company Name Cycle Computing Mailing Address Undisclosed Stamford, CT 06905 USA Company Description Cycle Computing is the leader in cloud computing orchestration software for Big Compute and Big Data. The company believes that greater access to compute enables people to ask bigger questions, faster answers and a better world. … Continue reading “Cycle Computing Obtains New Funding Round”

Ava Secures $3,000,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=04a154c1-4d59-438c-b6bf-29f98d38c27b Date 6/14/2016 Company Name Ava Mailing Address 222 Third Street Cambridge, MA 02142 USA Company Description At the intersection of nutrition and technology, AVA offers an intelligent solution that changes the way people think about healthy eating. AVA is a messaging-based service – there’s no app to download, so it’s easy … Continue reading “Ava Secures $3,000,000 Seed Round”

OceanGate Leads Underwater Expedition to “Mount Everest” of Shipwrecks

The first manned submersible mission in two decades to the Andrea Doria shipwreck located off the New England coast—a treacherous dive considered the underwater equivalent of climbing Mount Everest—has produced the first close-up sonar images of the vessel. The early findings? The ship’s deterioration appears worse than previously thought, as a chunk of the bow … Continue reading “OceanGate Leads Underwater Expedition to “Mount Everest” of Shipwrecks”

A Few Tickets Still Remain for Influx—Register Today for June 22

Time is almost up to grab a seat for Influx, Xconomy’s newest event that will convene Boston’s top innovators and influencers. Register today and save with our Innovation special while it lasts. Influx is an event you don’t want to miss this summer, and it’s all happening next week on June 22 at the Museum … Continue reading “A Few Tickets Still Remain for Influx—Register Today for June 22”

Eleven Bio, Still Breathing, Sells Eye Drug to Roche

[Corrected, 6/14/16, see below] Eleven Biotherapeutics’s (NASDAQ: [[ticker:EBIO]]) may be in strategic limbo, but today it’s gotten some cash to help figure out its next steps. The Cambridge, MA-based company licensed EBI-031, an experimental, preclinical drug it’s been developing for eye diseases like diabetic macular edema and uveitis, to Swiss pharma giant Roche. Eleven got … Continue reading “Eleven Bio, Still Breathing, Sells Eye Drug to Roche”

Perkins School for the Blind Pushes Into Apps, Driverless Cars

Perkins School for the Blind has a long history of breaking new ground, from becoming America’s first school for blind people in 1829, to creating a more effective and durable braille-writing machine in the mid-20th century. Now, under the leadership of Dave Power, the Boston-area school is exploring new ways of improving the lives of … Continue reading “Perkins School for the Blind Pushes Into Apps, Driverless Cars”

Notarize Lands $8,000,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45ac349e-3ffa-4224-badd-b0165c2803c3 Date 6/13/2016 Company Name Notarize Mailing Address Undisclosed Boston, MA 02108 USA Company Description Notarized documents serve an important and enduring part of the American economy. While any document can be signed, certain documents must be verifiably accepted and signed before an official Notary Public. Website http://www.notarize.com Transaction Type Venture Equity … Continue reading “Notarize Lands $8,000,000 Series A Funding”

Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another

Two days after news from one anemia drug program sent its stock down more than 20 percent, Agios Pharmaceuticals (NASDAQ: [[ticker:AGIO]]) is reporting promising data from a second anemia treatment. In an interview, CEO David Schenkein downplayed the information, which emerged Thursday, that a healthy volunteer developed thrombocytopenia, or low platelets, after taking the experimental … Continue reading “Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another”

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

If you blinked, you probably missed something this week in biotech. The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. In Boston, there were more twists for a closely watched Duchenne muscular dystrophy drug and a setback for a high-profile drug for multiple … Continue reading “Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More”

Qadium Reaps $20M Venture Round For IoT Device Search Engine

Tim Junio was a young security consultant for DARPA, the tech research division of the U.S. Department of Defense, when the agency called for responses to an interesting challenge. That was: Propose a way that a bad actor could cause catastrophic harm to the nation’s economy just by tapping into data that is generally available. … Continue reading “Qadium Reaps $20M Venture Round For IoT Device Search Engine”

Cheers, Groans, & Tunes: Boston Tech’s Week of Mixed Emotions

This week in Boston tech, we saw investors back software plays in eSports, real estate, and furniture for urban millennials; layoffs at a “sharing economy” pioneer; the return of a startup accelerator; and a first look at elegant connected speakers from serial entrepreneur Tom DeVesto’s new company. Read on for details. —Buildium said it received … Continue reading “Cheers, Groans, & Tunes: Boston Tech’s Week of Mixed Emotions”

Gamer Sensei Obtains $2,300,000 Seed Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cbfb547b-5836-4dd0-9c33-472c5061f9b6 Date 6/10/2016 Company Name Gamer Sensei Mailing Address Undisclosed Boston, MA 02410 USA Company Description Gamer Sensei currently offers personalized coaching and skills development for Hearthstone, Overwatch, League of Legends, DOTA2, Heroes of the Storm and Starcraft II. Website http://www.gamersensei.com Transaction Type Venture Equity Transaction Amount $2,300,000 Transaction Round Seed Proceeds … Continue reading “Gamer Sensei Obtains $2,300,000 Seed Financing”

Autodesk, EMC, Project 11 Join Influx Program on June 22

Xconomy is gearing up for a super fun afternoon at the Museum of Science in Boston on June 22. The theme of this year’s conference is Influx—welcoming prominent newcomers to the technology and innovation scene, and introducing them to longstanding leaders in the community who are also blazing new trails. The companies represented include GE, … Continue reading “Autodesk, EMC, Project 11 Join Influx Program on June 22”

Techstars Alum Netra Nabs Funding, Customers After Strategy Shift

Computer vision might one day enable things like completely autonomous cars, but for now, companies are more frequently applying such technology to more tractable (and lucrative) problems in sectors like marketing and e-commerce. The latest example is Netra, a nearly three-year-old Boston startup that today announced $1.85 million in new venture funding led by Launchpad … Continue reading “Techstars Alum Netra Nabs Funding, Customers After Strategy Shift”